SRF and skin basal cell carcinoma: Genomic analysis of human and murine vismodegib-resistant BCC identified serum response factor (SRF) and its coactivator megakaryoblastic leukemia 1 (MKL1) as noncanonical potentiators of GLI1 activation [203].